Iranian Journal of Medical Sciences

Document Type : Letter(s) to the Editor

Authors

1 Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Dermatology, Skin and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Dermatology Skin Diseases and Leishmaniasis Research Center School of Medicine Isfahan University of Medical Sciences Isfahan Iran

10.30476/ijms.2023.98516.3053

Abstract

Hair loss, which is known as telogen effluvium (TE), was reported in COVID-19 patients both during and after their recovery.

Keywords

  1. Hussain N, Agarwala P, Iqbal K, Omar HMS, Jangid G, Patel V, et al. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol. 2022;94:1391-401. doi: 10.1002/jmv.27534. PubMed PMID: 34931698.
  2. Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2022;191:1677-81. doi: 10.1007/s11845-021-02754-5. PubMed PMID: 34467470; PubMed Central PMCID: PMCPMC8407603.
  3. Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life. 2022;15:631-4. doi: 10.25122/jml-2021-0380. PubMed PMID: 35815081; PubMed Central PMCID: PMCPMC9262270.
  4. Torres F, Tosti A. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. Semin Cutan Med Surg. 2015;34:67-71. doi: 10.12788/j.sder.2015.0142. PubMed PMID: 26176282.
  5. Miola AC, Florencio LC, Bellini Ribeiro ME, Alcantara GP, Muller Ramos P, Miot HA. Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization. J Am Acad Dermatol. 2022;86:e207-e8. doi: 10.1016/j.jaad.2021.09.072. PubMed PMID: 34906662; PubMed Central PMCID: PMCPMC8665661.